Markers of angiogenesis and clinical features in patients with sarcoma.
about
Pazopanib in the management of advanced soft tissue sarcomasTargeted antiangiogenic agents in combination with cytotoxic chemotherapy in preclinical and clinical studies in sarcomaPazopanib in sarcomas: expanding the PALETTEUnderstanding the Biology of Bone Sarcoma from Early Initiating Events through Late Events in Metastasis and Disease ProgressionMicroenvironmental Targets in SarcomaPazopanib in the treatment of soft tissue sarcomaG-Protein coupled receptor 64 promotes invasiveness and metastasis in Ewing sarcomas through PGF and MMP1Systemic analysis of gene expression profiles identifies ErbB3 as a potential drug target in pediatric alveolar rhabdomyosarcomaOsteotropic cancer diagnosis by an osteocalcin inspired molecular imaging mimetic.Targeting angiogenesis-dependent calcified neoplasms using combined polymer therapeuticsNeoadjuvant multidrug chemotherapy including high-dose methotrexate modifies VEGF expression in osteosarcoma: an immunohistochemical analysis.Pediatric Osteosarcoma: An Updated ReviewProfiling of VEGFs and VEGFRs as prognostic factors in soft tissue sarcoma: VEGFR-3 is an independent predictor of poor prognosis.Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcomaPazopanib for the treatment of soft-tissue sarcoma.Vascularity of nongynecological leiomyosarcoma depends on colony-stimulating factor 1 but not on vascular endothelial growth factor.CSF1 expression in nongynecological leiomyosarcoma is associated with increased tumor angiogenesis.Serum tumor markers in pediatric osteosarcoma: a summary review.VEGF silencing inhibits human osteosarcoma angiogenesis and promotes cell apoptosis via PI3K/AKT signaling pathway.Unique antitumor property of the Mg-Ca-Sr alloys with addition of Zn.Alpha-CaMKII plays a critical role in determining the aggressive behavior of human osteosarcoma.Phase I trial of concurrent sunitinib and radiation therapy as preoperative treatment for soft tissue sarcomaImmunohistochemical expression of vegf and her-2 proteins in osteosarcoma biopsies.Malignant peripheral nerve sheath tumour (MPNST): the clinical implications of cellular signalling pathways.The emerging role of mammalian target of rapamycin inhibitors in the treatment of sarcomas.Cytokines as potential tumour markers.Crude Fucoidan Extracts Impair Angiogenesis in Models Relevant for Bone Regeneration and Osteosarcoma via Reduction of VEGF and SDF-1.Vascular patterning in human heterotopic ossification.Inhibition of Growth and Metastasis of Tumor in Nude Mice after Intraperitoneal Injection of Bevacizumab.Pharmacological therapies for Liposarcoma.Anti-angiogenesis target therapy for advanced osteosarcoma (Review).Enhanced anti-tumor activity and safety profile of targeted nano-scaled HPMA copolymer-alendronate-TNP-470 conjugate in the treatment of bone malignances.High-risk gastrointestinal stromal tumour (GIST) and synovial sarcoma display similar angiogenic profiles: a nude mice xenograft study.Association of the vascular endothelial growth factor (VEGF) gene single-nucleotide polymorphisms with osteosarcoma susceptibility in a Chinese population.Array comparative genomic hybridization reveals frequent alterations of G1/S checkpoint genes in undifferentiated pleomorphic sarcoma of bone.Systemic Therapy in Metastatic or Unresectable Well-Differentiated/Dedifferentiated Liposarcoma.Imaging of highly malignant osteosarcoma with iodine-123-vascular endothelial growth factor.VEGF Silencing Inhibits Human Osteosarcoma Angiogenesis and Promotes Cell Apoptosis via PI3K/AKT Signaling Pathway.The early stages of tumor angiogenesis in human osteosarcoma: a nude mice xenotransplant model.Frequent deletion of CDKN2A and recurrent coamplification of KIT, PDGFRA, and KDR in fibrosarcoma of bone--an array comparative genomic hybridization study.
P2860
Q26746205-0A85F354-9E6F-4489-B80B-2B192754DD26Q26747666-545BBD65-669D-4F43-9206-82106D569490Q26825050-1B0BA190-1215-45DC-9B87-4B5E34F2E127Q26829949-5FD7B0A5-33F8-4DD5-A1E8-E7B1F6EA8443Q28081400-7C672C47-126F-4D44-BBAA-117D38004CA6Q28269229-0C1AB391-BF64-4B44-A1C5-72E31B3519B5Q28283859-88BF9D71-B2AD-43AB-9202-F42935EDB546Q28485467-EFD30B6D-2AC5-44F1-B5ED-68F1BF15E415Q30410361-DA275671-A5EA-4891-AC26-B4595EAB8C59Q33432776-14B3E002-B079-4C35-A187-A61FC56070B8Q33531554-53855E34-BEE5-4C72-89F7-62CE4122E90CQ33583291-3B2EC5F1-39D3-43C0-AB06-E9080CA958ACQ33778580-9EB999A5-D5DB-4976-8BB9-86105FBC8D8BQ34628523-0FE39C79-6AD1-48EA-949E-9ACEBC5AC192Q34645938-2589B4AD-4F9B-46D7-AB1E-38AD08CD7425Q35235604-43E34C12-F082-4DD7-807A-F22717D0A950Q35235635-123EB78C-E303-43A0-839E-3F337E40FC54Q35984687-4573200D-B7EC-4E28-959A-8CD01EF7F388Q36182716-EC805AA3-58B5-441B-896B-55AF9D85F02CQ36610950-FBA2C4F1-100B-4B7B-AF06-7569239B7350Q36780837-5844602E-D181-4EF3-92AC-1BEB9BE156E5Q37190323-8D30DBD1-33B4-4213-8909-8BEFC8C799FCQ37389600-EFA922A4-DF1B-41FD-B612-67E9CBACBBFEQ37616238-D2D70585-7CF1-4C9A-A9A6-6F50BE4D27D4Q37870754-E6C42332-08E1-4B72-82A7-E2B73A920B05Q38089767-A7D19F8F-5F9A-4566-83F5-E4488749B67CQ38699675-6C0B6ABB-19B6-4A47-A380-B2419B05B72FQ38743308-27168187-6A55-44A6-8FF2-4C9622428A99Q38759471-F10CCCA9-C994-4A2E-913A-783EC504975DQ38991731-FAFF0EE0-A6E1-45C2-8E78-C436784CF6CCQ39401628-012B3067-04AD-46C3-B778-8067A670046CQ39571989-A1F061FD-6E07-4BA3-B553-F43EE4C0008BQ41950745-72DAF746-B5D6-4A60-8B6B-227BF225F1C4Q44122884-784F695E-FE82-4014-9FCA-E266B9C133B6Q45125767-BB7530E5-6F56-42EB-806C-0E42CB8345AAQ47144710-BB99F81D-C9A0-4EB5-907A-E1D74776B285Q51330391-BBECDD3E-ECFB-4824-9FDE-DE92FF1D67B0Q51676545-2E1CF02A-57F1-4D16-A44D-877314BCC930Q53474818-ABF3CC54-F669-4621-932C-946C68FA0B11Q54712822-7C8B9661-E851-43EF-8587-54530FBF82DC
P2860
Markers of angiogenesis and clinical features in patients with sarcoma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Markers of angiogenesis and clinical features in patients with sarcoma.
@ast
Markers of angiogenesis and clinical features in patients with sarcoma.
@en
type
label
Markers of angiogenesis and clinical features in patients with sarcoma.
@ast
Markers of angiogenesis and clinical features in patients with sarcoma.
@en
prefLabel
Markers of angiogenesis and clinical features in patients with sarcoma.
@ast
Markers of angiogenesis and clinical features in patients with sarcoma.
@en
P356
P1433
P1476
Markers of angiogenesis and clinical features in patients with sarcoma.
@en
P2093
George Demetri
Steven DuBois
P304
P356
10.1002/CNCR.22455
P407
P577
2007-03-01T00:00:00Z